3D Printed Mask Adapter Designed From Facial 3D Scans for Fit Testing.

Sponsor
Barts & The London NHS Trust (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05143814
Collaborator
(none)
50
12

Study Details

Study Description

Brief Summary

Healthcare workers PPE (personal protective equipment) when interacting with patients either infected or, potentially carrying SARS-CoV-2. One of the major routes of transmission is via droplet spread through oral and nasal mucosa therefore respiratory protective equipment (RPE) is an important part of PPE. There are concerns in dentistry that droplet spread can be increased during aerosol-generating procedures (AGP). This poses an increased risk to dentists and allied professionals in a clinical setting.

Fit testing is needed to ensure a mask forms a facial seal around the mouth and nose. Using a respirator mask without fit testing can reduce its effectiveness from between 6-88% with an optimal facial seal being more critical than the filtering performance. Commercial respirator masks are mass-produced for ' standard' faces, and often fail to provide a good fit for users thereby compromising the intended respirator filtering capability.

Given the high level of fit test failures, without the provision of improved fits of masks, patient care will be highly curtailed for frontline staff at risk of SARS-CoV-2. Therefore, a reusable bespoke 3D printed mask adapter used with a soft FFP3 disposable mask provides an economical solution to address the passing of fit testing.

Barts Health NHS Trust staff members who have previously failed the fit test to the first line FFP3 disposable respirator will be invited to enrol in this study.

Barts/QMUL scan App will be used to capture the facial scan of the subjects using a research allocated smartphone. Participants will be asked to be clean-shaven without any facial jewellery which could hinder the scan data. The App automatically generates a customized 3D print file (.stl) which will be sent for 3D printing.

The mask adapter will be fitted over the first-line FFP3 respirator once it is properly worn and checked as per the procedure.

Condition or Disease Intervention/Treatment Phase
  • Device: 3D Printed Mask Adapter Designed from Facial 3D scans for Fit testing.

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Prospective Cohort Study Investigating the Success Rate of Fit Testing Following the Use of a 3D Printed Respirator Adapter From a Facial 3D Scan.
Anticipated Study Start Date :
Apr 15, 2022
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Apr 15, 2023

Outcome Measures

Primary Outcome Measures

  1. The success of of fit testing will be measured and reported quantitively using a TSI portacount [20 minutes mask fit test]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Subjects who would have previously failed the quantitative fit test on the Trust's first line FFP3 disposable respirator.

  • Subjects willing to use a flexible, disposable FFP3 mask.

  • Subjects should be a minimum of 18 years old.

Exclusion Criteria:
  • Subjects unwilling or unable to give written consent.

  • Subjects who cannot remove their facial hair for religious or other reasons.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Barts & The London NHS Trust

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Barts & The London NHS Trust
ClinicalTrials.gov Identifier:
NCT05143814
Other Study ID Numbers:
  • 289974
First Posted:
Dec 3, 2021
Last Update Posted:
Mar 29, 2022
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 29, 2022